FOXO1 and diabetes mellitus: Immunofluorescence results indicated an increase of FOXO1 nucleus accumulation in AVE 0991-treated diabetic cognitive impairment mice, suggesting the enhancement of FOXO1 transcriptional activity (Figure 6F).